Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: An in vivo microdialysis approach in guinea pig

Neuropeptides

Volumn 32, Issue 5, 1998, Pages 481-488

  Marco, N ^a   Thirion, A ^a   Mons, G ^a   Bougault, I ^a   Le Fur, G ^a   Soubrie P ^a   Steinberg, R ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLINE; DOPAMINE; OSANETANT;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC TRANSMISSION; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC TRANSMISSION; HIPPOCAMPUS; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR UPREGULATION;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0031768558     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(98)90075-0     Document Type: Article

References (33)

1. Mussap C J, Geraghty D P, Burcher E. Tachykinin receptors: a radioligand binding perspective. J Neurochem. 1993; 60: 1987-2009.
2. Marksteiner J, Saria A, Krause J E. Comparative distribution of neurokinin B-, substance P- and enkephalin-like immunoreactivities and neurokinin B messenger RNA in the basal forebrain of the rat: evidence for neurochemical compartmentation. Neuroscience 1992; 51: 107-120.
3. Merchenthaler I, Maderdrut J L, O'Harte F, Conlon J M. Localization of neurokinin B in the central nervous system of the rat. Peptides 1992; 13: 815-829.
4. Chawla M K, Gutierrez G M, Young W S S et al. Localization of neurons expressing substance P and neurokinin B gene transcripts in the human hypothalamus and basal forebrain. J Comp Neurol 1997; 384: 429-442.
5. Dam T-V, Escher E, Quirion R. Visualization of neurokinin-3 receptor sites in rat brain using the highly selective ligand [3H]senktide. Brain Res 1990; 506: 175-179.
6. Stoessl A J. Localization of striatal and nigral tachykinin receptors in the rat. Brain Res 1994; 646: 13-18.
7. Bannon M J, Whitty C J. Neurokinin receptor gene expression in substantia nigra: localization, regulation, and potential physiological significance. Can J Physiol Pharmacol 1995; 73: 866-870.
8. Shughrue P J, Lane M V, Merchenthaler I. In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system. J Comp Neurol 1996; 372: 395-414.
9. Keegan K D, Woodruff G N, Pinnock R D. The selective NK3 receptor agonist senktide excites a subpopulation of dopaminesensitive neurones in the rat substantia nigra pars compacta in vitro. Br J Pharmacol 1992; 105: 3-5.
10. Nalivaiko E, Michaud J C, Soubrie P et al. Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: an in vitro electrophysiological study. Neuroscience 1997; 78: 745-757.
11. Jung M, Michaud J C, Steinberg R et al. Electrophysiological, behavioural and biochemical evidence for activation of brain noradrenergic systems following neurokinin NK3 receptor stimulation. Neuroscience 1996; 74: 403-414.
12. Seabrook G R, Bowery B J, Hill R G. Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices. Eur J Pharmacol 1995; 273: 113-119.
13. Stoessl A J, Szczutkowski E, Glenn B, Watson I. Behavioral effects of selective tachykinin agonists in midbrain dopamine regions. Brain Res 1991; 565: 254-262.
14. Stoessl A J, Polanski E, Frydryszak H. Effects of ageing on tachykinin function in the basal ganglia. Brain Res 1993; 632: 21-28.
15. Bannon M J, Brownschidle L A, Tian Y et al. Neurokinin-3 receptors modulate dopamine cell function and alter the effects of 6-hydroxydopamine. Brain Res. 1995; 695: 19-24.
16. Humpel C, Saria A, Regoli D. Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism. Eur J Pharmacol 1991; 195: 107-114.
17. Humpel C, Saria A. Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat. Neurosci Lett 1993; 157: 223-226.
18. Emonds-Alt X, Bichon D, Ducoux J P et al. SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor. Life Sci 1995; 56: PL27-32.
19. Alonso R, Fournier M, Carayon P et al. Evidence for modulation of dopamine-neuronal function by tachykinin NK3 receptor stimulation in gerbil mesencephalic cell cultures. Eur J Neurosci 4-1996; 8: 801-808.
20. Oury-Donat F, Carayon P, Thurneyssen O et al. Functional characterization of the nonpeptide neurokinin3 (NK3) receptor antagonist, SR142801 on the human NK3 receptor expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther. 7-1995; 274: 148-154.
21. Koch M. The septohippocampal system is involved in prepulse inhibition of the acoustic startle response in rats. Behav Neurosci 6-1996; 110: 468-477.
22. Geyer M A, Swerdlow N R, Mansbach R S, Braff D L. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 1990; 25: 485-498.
23. Rapisarda C, Bacchelli B. The brain of the guinea pig in stereotaxic coordinates. Arch Sci Biol. 1977; 61: 1-37.
24. Gonon F, Buda M, Pujol J F. Measurement of neurotransmitter release. Mardsen, C. A. Chichester: John Wiley. 1984: 153-171.
25. Steinberg R, Brun P, Fournier M et al. SR48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behavior and changes in dopaminergic transmission. Neuroscience. 1994; 59: 921-929.
26. Steinberg R, Souilhac J, Kodier D et al. Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation. Neuroscience. 1998; 84: 511-518.
27. Reid M S, Herrera-Marschitz M, Terenius L, Ungestedt U. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments. Brain Res. 1990; 526: 228-234.
28. Steinberg R, Marco N, Voutsinos B et al. Expression and presence of septal neurokinin-2 receptors controlling hippocampal acetylcholine release during sensory stimulation in rat. Eur J Neurosci 1998; 10: 2337-2345.
29. Ding Y Q Shigemoto R, Takada M et al. Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat. J Comp Neurol 1996; 364: 290-310.
30. Burgunder J M, Young W S. Neurons with neurokinin B mRNA in the rat magnocellular basal nucleus: distribution, projection and colocalization studies. J Chem Neuroanat 1989; 2: 239-251.
31. Overton P, Elliott P J, Hagan R M, Clark D. Neurokinin agonists differentially affect A9 and AlO dopamine cells in the rat. Eur J Pharmacol 1992; 213: 165-166.
32. Baruch P, Artaud F, Godeheu G et al. Substance P and neurokinin a regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons. Neuroscience 1988; 25: 889-898.
33. Steinberg R, Rodier D, Souilhac J et al. Pharmacological characterization of tachykinin receptors controlling acetylcholine release from rat striatum: an in vivo microdialysis study. J Neurochem 1995; 65: 2543-2548.